✦ LIBER ✦

Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay

✍ Scribed by M. Untch; B.-U. Sevin; J.P. Perras; R. Angioli; A. Untch; R.D. Hightower; O. Koechli; H.E. Averette

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Paclitaxel (Taxol), Cispla

✍ Michael Untch; Bernd-Uwe Sevin; James P. Perras; Roberto Angioli; Andrea Untch; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Characteristics of the combination pacli

✍ Ossi R. Koechli; Bernd-Uwe Sevin; James P. Perras; Ting Chao Chou; Roberto Angio 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 588 KB

Combination chemotherapy with paclitaxel

✍ F. Terauchi; T. Moritake; Y. Yamamoto; H. Ogura 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 659 KB

Long-term follow-up confirms a survival

✍ M. J. Piccart; K. Bertelsen; G. Stuart; J. Cassidy; C. Mangioni; E. Simonsen; K. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

The Use of Paclitaxel and Cisplatin in a

✍ Stacey N. Knox; Jubilee B. Robinson; Dwight D. Im; Lisa Logan; Neil B. Rosenshei 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 411 KB